Pardaxin

General Information


DRACP ID  DRACP00334

Peptide Name   Pardaxin

Sequence  GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE

Sequence Length  33

UniProt ID  P81861 

PubChem CID  Not available

Origin  Red Sea Mosessole

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HT-1080 Fibrosarcoma Sarcoma IC50=15.74 µg/ml MTS assay 3 h 1
HT-1080 Fibrosarcoma Sarcoma IC50=15.40 µg/ml MTS assay 6 h 1
HT-1080 Fibrosarcoma Sarcoma IC50=14.51 µg/ml MTS assay 12 h 1
HT-1080 Fibrosarcoma Sarcoma IC50=14.52 µg/ml MTS assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  pardaxin disrupted mitochondrial function and caused an accumulation of ROS that activated a caspase-dependent intrinsic apoptotic pathway

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  1XC0 

Predicted Structure  DRACP00334

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C154H248N36O45

Absent amino acids  CDHMNRWY

Common amino acids  S

Mass  389483

Pl  9.54

Basic residues  2

Acidic residues  1

Hydrophobic residues  15

Net charge  1

Boman Index  1171

Hydrophobicity  74.55

Aliphatic Index  112.42

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  12

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22073006

Title  Pardaxin, an antimicrobial peptide, triggers caspase-dependent and ROS-mediated apoptosis in HT-1080 cells

Doi 10.3390/md9101995

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.